| Synonyms: | |
| Status: | Approved (1947) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | J01CE01 |
| UNII: | Q42T66VG0C |
| InChI Key | JGSARLDLIJGVTE-MBNYWOFBSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H18N2O4S |
| Molecular Weight | 334.4 |
| AlogP | 0.86 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 86.71 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 23.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | 20000 | - | |
|
Enzyme
Transferase
|
- | - | - | - | 13 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 41 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 89400 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Rheumatic Heart Disease | 2 | D012214 | ClinicalTrials |
| Syphilis | 2 | D013587 | ClinicalTrials |
| Pharyngitis | 1 | D010612 | ClinicalTrials |
| Osteomyelitis | 0 | D010019 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 18208 |
| ChEMBL | CHEMBL29 |
| DrugBank | DB01053 |
| DrugCentral | 2082 |
| EPA CompTox | DTXSID5046934 |
| FDA SRS | Q42T66VG0C |
| Human Metabolome Database | HMDB0015186 |
| Guide to Pharmacology | 4796 |
| KEGG | C05551 |
| PDB | PNN |
| PharmGKB | PA450842 |
| SureChEMBL | SCHEMBL3783 |
| ZINC | ZINC000003871701 |